To understand the mechanisms associated with ATP1A1 knockdown-elicited reduction of the tumorigenicity of HCC cells, we used a HumanHT-12 v4 array (Illumina, San Diego, CA, USA) to identify these mechanisms in HepG2 cells. This evidence concerns the gene ATP1A1 and hepatocellular carcinoma.